{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T18:21:03Z","timestamp":1774376463204,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jacl.2017.07.009","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T03:32:01Z","timestamp":1501558321000},"page":"1280-1283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Caveolin 3 deficiency myopathy associated with dyslipidemia: Treatment challenges and possible pathophysiological association"],"prefix":"10.1016","volume":"11","author":[{"given":"Daiana","family":"Ibarretxe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Pellej\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolau","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0789-4954","authenticated-orcid":false,"given":"Luis","family":"Masana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jacl.2017.07.009_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrm2122","article-title":"The multiple faces of caveolae","volume":"8","author":"Parton","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.jacl.2017.07.009_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1600-0854.2008.00733.x","article-title":"High-resolution 3D quantitative analysis of caveolar ultrastructure and caveola\u2013cytoskeleton interactions","volume":"9","author":"Richter","year":"2008","journal-title":"Traffic"},{"issue":"2","key":"10.1016\/j.jacl.2017.07.009_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00418-009-0651-8","article-title":"The shape of caveolae is omega-like after glutaraldehyde fixation and cup-like after cryofixation","volume":"133","author":"Schl\u00f6rmann","year":"2010","journal-title":"Histochem Cell Biol"},{"issue":"4","key":"10.1016\/j.jacl.2017.07.009_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0092-8674(92)90143-Z","article-title":"Caveolin, a protein component of caveolae membrane coats","volume":"68","author":"Rothberg","year":"1992","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jacl.2017.07.009_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrm3512","article-title":"Caveolae as plasma membrane sensors, protectors and organizers","volume":"14","author":"Parton","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.jacl.2017.07.009_bib6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cell.2004.09.003","article-title":"Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic","volume":"118","author":"Pelkmans","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jacl.2017.07.009_bib7","doi-asserted-by":"crossref","first-page":"C222","DOI":"10.1152\/ajpcell.00006.2003","article-title":"Caveolin-1-deficient mice show\u00a0insulin resistance and defective insulin receptor protein expression in adipose tissue","volume":"285","author":"Cohen","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"10.1016\/j.jacl.2017.07.009_bib8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tem.2011.04.001","article-title":"Fat caves: caveolae, lipid trafficking and lipid metabolism in adipocytes","volume":"22","author":"Pilch","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2017.07.009_bib9","doi-asserted-by":"crossref","first-page":"C242","DOI":"10.1152\/ajpcell.00185.2008","article-title":"Role of caveolin-1 in the regulation of lipoprotein metabolism","volume":"295","author":"Frank","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"issue":"10","key":"10.1016\/j.jacl.2017.07.009_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1471-4914(01)02105-0","article-title":"Caveolae and caveolin-3 in muscular dystrophy","volume":"7","author":"Galbiati","year":"2001","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.jacl.2017.07.009_bib11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1212\/WNL.62.4.538","article-title":"Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases","volume":"62","author":"Woodman","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jacl.2017.07.009_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ejhg.2009.103","article-title":"Caveolinopathies: from the biology of caveolin-3 to human diseases","volume":"18","author":"Gazzerro","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10.1016\/j.jacl.2017.07.009_bib13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mus.20307","article-title":"Rippling muscle disease may be caused by \u201csilent\u201d action potentials in the tubular system of skeletal muscle fibers","volume":"31","author":"Lamb","year":"2005","journal-title":"Muscle Nerve"},{"issue":"S11","key":"10.1016\/j.jacl.2017.07.009_bib14","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/mus.10156","article-title":"Rippling muscle disease: a review","volume":"999","author":"Torbergsen","year":"2002","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.jacl.2017.07.009_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.nmd.2016.05.006","article-title":"CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: expanding the phenotypic spectrum of caveolinopathies","volume":"26","author":"Scalco","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jacl.2017.07.009_bib16","doi-asserted-by":"crossref","first-page":"C1317","DOI":"10.1152\/ajpcell.00489.2004","article-title":"Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle","volume":"288","author":"Capozza","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"10.1016\/j.jacl.2017.07.009_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/mus.21589","article-title":"Bedside diagnosis of rippling muscle disease in CAV3 p.A46T mutation carriers","volume":"41","author":"Sundblom","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jacl.2017.07.009_bib18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy\u2014European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacl.2017.07.009_bib19","first-page":"276","article-title":"High cholesterol level upregulate the expression of caveolin-1","volume":"21","author":"Ran","year":"2004","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741730394X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741730394X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T17:21:06Z","timestamp":1535563266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328741730394X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S193328741730394X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2017.07.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caveolin 3 deficiency myopathy associated with dyslipidemia: Treatment challenges and possible pathophysiological association","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2017.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}